170 related articles for article (PubMed ID: 16026177)
1. Paroxetine-related tremor.
Lai H; Tolat R
Geriatrics; 2005 Jul; 60(7):18-20. PubMed ID: 16026177
[No Abstract] [Full Text] [Related]
2. Paroxetine-induced angioedema and tongue swelling.
Mithani H; Hurwitz TA
J Clin Psychiatry; 1996 Oct; 57(10):486. PubMed ID: 8909336
[No Abstract] [Full Text] [Related]
3. Recognition and treatment of serotonin syndrome.
Frank C
Can Fam Physician; 2008 Jul; 54(7):988-92. PubMed ID: 18625822
[No Abstract] [Full Text] [Related]
4. Paroxetine-induced somnambulism.
Kawashima T; Yamada S
J Clin Psychiatry; 2003 Apr; 64(4):483. PubMed ID: 12716257
[No Abstract] [Full Text] [Related]
5. Hyponatraemia associated with the use of a selective serotonin-reuptake inhibitor in an older patient.
Schouten WE; Sepers JM
Age Ageing; 2001 Jan; 30(1):94. PubMed ID: 11322690
[No Abstract] [Full Text] [Related]
6. More cases of paroxetine withdrawal syndrome.
Pacheco L; Malo P; Aragues E; Etxebeste M
Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
[No Abstract] [Full Text] [Related]
7. Case of gynecomastia during paroxetine therapy.
Damsa C; Sterck R; Schulz P
J Clin Psychiatry; 2003 Aug; 64(8):971. PubMed ID: 12927018
[No Abstract] [Full Text] [Related]
8. It's an ill pill.
Friedli L
Ment Health Today; 2004 May; ():8-9. PubMed ID: 15192924
[No Abstract] [Full Text] [Related]
9. Hypersensitivity to paroxetine.
Mera MT; Pérez BV; Fernández RO; Iglesias JF
Allergol Immunopathol (Madr); 2006; 34(3):125-6. PubMed ID: 16858890
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal syndromes after paroxetine and sertraline discontinuation.
Fava GA; Grandi S
J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
[No Abstract] [Full Text] [Related]
11. Paroxetine-induced anorexia in a patient with bulimia nervosa.
Sagduyu K
J Clin Psychiatry; 1997 May; 58(5):220-1. PubMed ID: 9184619
[No Abstract] [Full Text] [Related]
12. Depressing misrepresentation?
Newton J; Langlands A
Lancet; 2004 May; 363(9422):1732. PubMed ID: 15158640
[No Abstract] [Full Text] [Related]
13. FDA questions antidepressant safety for children.
Oransky I
Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000
[No Abstract] [Full Text] [Related]
14. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
Rone LA; Ferrando SJ
Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
[No Abstract] [Full Text] [Related]
15. Antidepressant treatment and global tests of coagulation and fibrinolysis.
Lederbogen F; Weber B; Colla M; Heuser I; Deuschle M; Dempfle CE
J Clin Psychiatry; 2001 Feb; 62(2):130. PubMed ID: 11247103
[No Abstract] [Full Text] [Related]
16. Paroxetine treatment of trichotillomania in an adolescent.
Block C; West SA; Baharoglu B
J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
[No Abstract] [Full Text] [Related]
18. Antidepressants and children. Buried data can be hazardous to a company's health.
Marshall E
Science; 2004 Jun; 304(5677):1576-7. PubMed ID: 15192185
[No Abstract] [Full Text] [Related]
19. Paroxetine and tardive dyskinesia.
Botsaris SD; Sypek JM
J Clin Psychopharmacol; 1996 Jun; 16(3):258-9. PubMed ID: 8784663
[No Abstract] [Full Text] [Related]
20. Effect of paroxetine on seizure length during electroconvulsive therapy.
Curran S
Acta Psychiatr Scand; 1995 Sep; 92(3):239-40. PubMed ID: 7484206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
